BBVA USA’s Repligen RGEN Stock Holding History

BBVA USA’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$126K	Sell	435 -72	-14%	-$18.5K	0.01%	512
2021 Q2	$101K	Buy	+507	New	+$98.4K	0.01%	560

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBVA USA's RGEN Position: Q3 2021 in Review

BBVA USA reduced its Repligen (RGEN) stake by 14% in Q3 2021, selling an estimated $18.5K and leaving 435 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #512.

BBVA USA first reported a position in RGEN in Q2 2021 and has held it in 2 quarters since. 478 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

BBVA USA held 435 shares of Repligen worth $126K as of Q3 2021.
BBVA USA sold 72 Repligen shares in Q3 2021, an estimated $18.5K.
Repligen made up 0.01% of BBVA USA's portfolio in Q3 2021, its #512 holding.
BBVA USA first reported a position in Repligen in Q2 2021 and has held it in 2 quarters since.
478 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.